Global Diltiazem Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Diltiazem Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Diltiazem is a nondihydropyridine (non-DHP) calcium channel blocker used in the treatment of hypertension, angina pectoris, and some types of arrhythmia. It relaxes the smooth muscles in the walls of arteries, which opens (dilates) the arteries, allows blood to flow more easily, and lowers blood pressure. Additionally, it lowers blood pressure by acting on the heart itself to reduce the rate, strength, and conduction speed of each beat.
Diltiazem report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Diltiazem market is projected to reach US$ 505 million in 2029, increasing from US$ 336 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2029. Demand from Angina and Hypertension are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Diltiazem industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Diltiazem key manufacturers include Bausch Health, Teva, Mylan, Athenex, Pfizer, Akorn, Sandoz, Sun Pharma and Hikma Pharmaceuticals, etc. Bausch Health, Teva, Mylan are top 3 players and held % sales share in total in 2022.
Diltiazem can be divided into Tablet, Capsule and Injection,, etc. Tablet is the mainstream product in the market, accounting for % sales share globally in 2022.
Diltiazem is widely used in various fields, such as Angina and Hypertension, etc. Angina provides greatest supports to the Diltiazem industry development. In 2022, global % sales of Diltiazem went into Angina filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Diltiazem market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Bausch Health
Teva
Mylan
Athenex
Pfizer
Akorn
Sandoz
Sun Pharma
Hikma Pharmaceuticals
Zydus Pharmaceuticals
Par Pharmaceutical
Segment by Type
Tablet
Capsule
Injection
Angina
Hypertension
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Diltiazem market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Diltiazem, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Diltiazem industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Diltiazem in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Diltiazem introduction, etc. Diltiazem Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Diltiazem market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Diltiazem report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Diltiazem market is projected to reach US$ 505 million in 2029, increasing from US$ 336 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2029. Demand from Angina and Hypertension are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Diltiazem industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Diltiazem key manufacturers include Bausch Health, Teva, Mylan, Athenex, Pfizer, Akorn, Sandoz, Sun Pharma and Hikma Pharmaceuticals, etc. Bausch Health, Teva, Mylan are top 3 players and held % sales share in total in 2022.
Diltiazem can be divided into Tablet, Capsule and Injection,, etc. Tablet is the mainstream product in the market, accounting for % sales share globally in 2022.
Diltiazem is widely used in various fields, such as Angina and Hypertension, etc. Angina provides greatest supports to the Diltiazem industry development. In 2022, global % sales of Diltiazem went into Angina filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Diltiazem market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Bausch Health
Teva
Mylan
Athenex
Pfizer
Akorn
Sandoz
Sun Pharma
Hikma Pharmaceuticals
Zydus Pharmaceuticals
Par Pharmaceutical
Segment by Type
Tablet
Capsule
Injection
Segment by Application
Angina
Hypertension
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Diltiazem market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Diltiazem, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Diltiazem industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Diltiazem in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Diltiazem introduction, etc. Diltiazem Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Diltiazem market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices